Combination of everolimus and exemestane reduces spread of cancer in the bone News-Medical.net Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of ... |
